Recent stressful life events in euthymic MDD patients: sociodemographic and clinical characteristics by Serafini, Gianluca et al.
Frontiers in Psychiatry | www.frontiersin.or
Edited by:
Manit Srisurapanont,
Chiang Mai University, Thailand
Reviewed by:
George P. Chrousos,
National and Kapodistrian University of
Athens, Greece
Liliana Dell’Osso,





This article was submitted to
Mood and Anxiety Disorders,
a section of the journal
Frontiers in Psychiatry
Received: 26 May 2020
Accepted: 17 August 2020
Published: 11 September 2020
Citation:
Serafini G, Gonda X, Canepa G,
Geoffroy PA, Pompili M and Amore M
(2020) Recent Stressful Life Events in






published: 11 September 2020
doi: 10.3389/fpsyt.2020.566017Recent Stressful Life Events in
Euthymic Major Depressive Disorder
Patients: Sociodemographic and
Clinical Characteristics
Gianluca Serafini1,2*, Xenia Gonda3,4,5, Giovanna Canepa1,2, Pierre A. Geoffroy6,7,
Maurizio Pompili 8 and Mario Amore1,2
1 Section of Psychiatry, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health,
University of Genoa, Genoa, Italy, 2 IRCCS Ospedale Policlinico San Martino, Genoa, Italy, 3 Department of Psychiatry and
Psychotherapy, St. Rokus Clinical Center, Semmelweis University, Budapest, Hungary, 4 MTA-SE Neuropsychopharmacology
Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary, 5 NAP-2-SE New
Antidepressant Target Research Group, Hungarian Brain Research Programme, Semmelweis University, Budapest, Hungary,
6 Department of Psychiatry and Addiction Medicine, AP-HP, Hopital Bichat-Claude Bernard, Paris, France, 7 NeuroDiderot,
Inserm, Paris University, Paris, France, 8 Department of Neurosciences, Suicide Prevention Center, Sant’Andrea Hospital,
University of Rome, Rome, Italy
Background: Stressful life events (SLE) may influence the illness course and outcome.
This study aimed to characterize socio-demographic and clinical features of euthymic
major depressive disorder (MDD) outpatients with SLE compared with those without.
Methods: The present sample included 628 (mean age=55.1 ± 16.1) currently euthymic
MDD outpatients of whom 250 (39.8%) reported SLE and 378 (60.2%) did not.
Results: After univariate analyses, outpatients with SLE were most frequently widowed and
lived predominantly with friends/others. Moreover, relative to outpatients without SLE, those
with SLE were more likely to have a family history of suicidal behavior, manifested melancholic
features, report a higher Coping Orientation to the Problems Experienced (COPE) positive
reinterpretation/growth and less likely to have a comorbid panic disorder, residual
interepisodic symptoms, use previous psychiatric medications, and currently use of
antidepressants. Having a family history of suicide (OR=9.697; p=≤.05), history of
psychotropic medications use (OR=2.888; p=≤.05), and reduced use of antidepressants
(OR=.321; p=.001) were significantly associated with SLE after regression analyses.
Mediation analyses showed that the association between current use of antidepressants
and SLE was mediated by previous psychiatric medications.
Conclusion: Having a family history of suicide, history of psychotropic medications use,
and reduced use of antidepressants is linked to a specific “at risk” profile characterized by
the enhanced vulnerability to experience SLE.
Keywords: negative distressing/stressful life events, family history of suicide, major depressive disorder, previous
psychiatric medications, antidepressant medicationsg September 2020 | Volume 11 | Article 5660171
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Stressful life events (SLE) may be defined as: “environmental
events or chronic conditions that objectively threaten the
physical and/or psychological health or well-being of
individuals of a particular age in a particular society” (1). Life
events may be described as social and environmental occurrences
leading to psychophysiological modification in the general
population during the time course (2). Life events are
considered positive or negative according to the individual’s
subjective experience. Negative life events, which may have a
prominent role in the development and clinical course of
psychiatric disorders may be identified in various social/
environmental contexts (2) and may be commonly defined as:
1) maltreatment and violence; 2) loss events; 3) intrafamilial
problems; 4) school and interpersonal problems (3, 4). These
type of life events are usually associated with undesirable affective
experiences exerting deleterious effects on the individual mental
health and social/environmental adaption (4). Generally, SLE
such as perceived loss, humiliation, entrapment, and perceived
danger seem to provide interesting information about the course
and outcome of psychiatric conditions (5). Notably, certain types
of SLE such as involuntary occupation loss and marital
separation may enhance suicide risk (6, 7), and influence the
time to remission of major depressive disorder (MDD) (8) as well
as substance use (9).
Based on stress vulnerability models, having experienced SLE
is generally linked to poor mental health (10) with the
development of major psychiatric conditions generally
associated with the exposure to SLE (11). Having experienced
more proximal life personal and situational factors may also
enhance suicide risk (12) with the cumulative effect of multiple
life events playing a more relevant effect than that of specific
single life events (13).
While depression has a moderate heritability, environmental
events account for approximately 60% of the variation in
depression (14) on a general population level depending on the
severity of the illness, with 80% of depressive episodes preceded
by a major stress exposure (15) and etiologically relevant distal
and proximal stressors occurring quite frequently, about at least
once every 3–4 years.
SLE are able to strongly predict both the onset (16) and
recurrence (17) of depressive episodes, including suicidal
behavior. Evidence also suggested that negative life adversities
are important risk factors particularly for depressed subjects with
a negative cognitive style (18). This hypothesis postulated that
exposure to SLE may determine sensitization or kindling and
may enhance the individual vulnerability to manifest depressive
episodes, although the patient is not directly experiencing a
relevant psychosocial stressor. Socio-demographic and clinical
variables such as gender potentially mediate the relation between
SLE and depression. For instance, when compared to males,
females seem to be more vulnerable to the adverse effects of
psychosocial stressors (19). Studies (19, 20) stressed the link
between the personality trait “neuroticism,” which increases the
likelihood of maladaptive responses and coping in the face of
negative life events and increased sensitivity to stress and severityFrontiers in Psychiatry | www.frontiersin.org 2of MDD. Importantly, Kendler and colleagues (20) found that, in
a sample of more than 7500 twins, higher neuroticism enhanced
the likelihood of depressive episodes in response to SLE.
The above indicates that SLE should be taken into
consideration in affective disorder patients due to their impact
on illness course and outcomes including suicide. Thus, the
present study aimed to compare socio-demographic/clinical
characteristics (including marital and living level, family
history of psychiatric conditions and/or suicidal behavior,
melancholic characteristics in the past, residual interepisodic
symptoms, psychiatric medications in the past, current
antidepressant medications use, and specific psychometric
measures) of euthymic MDD outpatients experiencing
significant SLE in the previous 6 months and those who did
not, focusing on specific features that may explain the
differential burden of disease directly linked to having or not
experienced recent SLE. Our aim was also to test whether the
effect of current antidepressants use on SLE was mediated by
specific variables (i.e., previous psychiatric medications, family
history of suicide). Here, we mainly hypothesize that previous
psychiatric medications have a significant direct/indirect effect
on SLE.METHODS
Sample
The present sample is composed of 628 currently euthymic MDD
outpatients with age ranging from 18 to 85 years (mean age=55.1 ±
16.1). Clinically, euthymia was defined using a Montgomery–
Asberg Depression Rating Scale (MADRS) (21) score of <10.
Our sample included predominantly single MDD outpatients
(52.9%) and, in a relatively smaller proportion, recurrent MDD
outpatients (47.1%). Participants are all consecutive euthymic
unipolar outpatients receiving only maintenance treatment at the
time of evaluation. Overall, 488 subjects (77.7%) of our sample
were treated with antidepressant medications and 140 individuals
(22.3%) received only psychotherapy as maintenance. In particular,
psychopharmacological treatments and psychopathological
conditions were stable for at least 6 months before assessment.
All euthymic MDD outpatients were recruited from our catchment
area and have been followed/treated by our university outpatient
service for at least 12 months. In addition, they were regularly
followed by our local psychiatric services.
Measures and Study Design
An investigator (GC) who was adequately trained to improve the
interrater reliability administered to participants the following
psychometric instruments: 1) Clinical Global Impression (CGI)
(22); 2) Beck Hopelessness Scale (BHS) (23); 3) Hamilton
Anxiety Rating Scale (HARS) (24); 4) Global Assessment of
Functioning Scale (GAF) (American Psychiatric Association,
1987) (25); 5) Childhood Trauma Questionnaire (CTQ) (26);
6) Coping Orientation to the Problems Experienced (COPE)
(27); 7) Toronto Alexithymia Scale (TAS-20) (28) to collect other
relevant clinical information.September 2020 | Volume 11 | Article 566017
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clinical files and lifetime computerized medical records. All
outpatients accepted voluntarily to participate in the present
study and provided their informed consent to participate. The
local Ethical Review Board regularly approved the specified
study design.
Ascertainment of Recent Stressful
Life Events
Significant stressful/distressing life-events in the previous 6
months were collected based on self-report and described as
follows: 1) maltreatment and violence (sexual/physical/
emotional abuse, emotional/physical neglect, witnessing home/
community aggression); 2) loss events (separations, death of a
parent or close friend); 3) intrafamilial problems (parental
divorce, family instability, social or economic problems); 4)
school and interpersonal problems (failure of grade in school
or in exam, breaking up with a close friend, and poor social
relationships) (for more details, see 3 and 4).Procedure and Data Collection
All MDD outpatients were recruited at the Department of
Neuroscience (DINOGMI), University of Genoa, outpatient
service, between July 2014 and February 2020. We used the
following inclusion criteria: 1) a diagnosis of single/recurrent
MDD; 2) euthymia; 3) a current age of >18 years. Depressive
symptoms related to MDD were classified based on the Diagnostic
and Statistical Manual of Mental Disorders, 5th edition (DSM-5)
(29). First, an investigator (GC) examined clinical records to retrace
subjective histories and clinical variables; then, two senior authors
(GS, MA) systematically and independently verified data by using
the Mini International Neuropsychiatric Interview (MINI) (30)
updated to map to DSM-5 (29). Direct interviews with patients/
family members as well as investigation of existing medical records
allow the detailed collection of clinical information regarding
affective episodes prior the patients’ recruitment in our outpatient
service. Specifically, we performed a comprehensive data collection
using the following variables: 1) socio-demographic information; 2)
individual data (e.g., personal autonomy, lifetime substance abuse/
dependence, use of psychiatric medications and psychotherapy in
the past); 3) positive history of clinical conditions/negative outcome
in family (e.g., psychiatric disorders and suicidal behavior); 4)
comorbid conditions (e.g., medical/psychiatric disorders); 5)
illness course features (e.g., manifested melancholic features and/
or current atypical depressive characteristics, seasonality, psychotic
symptoms at first episode, single/recurrent episode, residual
interepisodic symptoms, illness duration and untreated illness,
current illness episode, number of previous affective episodes, age
of illness onset, age at first treatment and first hospitalization, and
lifetime suicide attempts).
Exclusion criteria were as follows: 1) all clinical conditions
that may influence the ability to complete the evaluations
including conditions such as Alzheimer’s disease, delirium, or
severe neurological disorders like intellectual disability; 3) denial
of informed consent, 4) a history of active abuse/dependenceFrontiers in Psychiatry | www.frontiersin.org 3(throughout the previous 6 months). Lifetime substance use
emerging during mental examination, was not considered a
specific exclusion criterion. Intellectual disability was
investigated using the Wechsler Adult Intelligence Scale (31).
Statistical Analyses
Subjects were categorized based on the presence/absence of SLE
in the previous 6 months and divided into two groups similarly
to existing published studies (32) outpatients with recent SLE
and 2) outpatients without recent SLE. Data for categorical
variables were analyzed using Student’s t-tests and Pearson
chi-square/Fisher’s exact test in contingency tables (c2). The
Kolmogorov–Smirnov test was performed to confirm whether all
the investigated variables in the sample followed the normal
distribution. Significance was set at P ≤ 0.05 (two-tailed).
A binary logistic regression analysis considering specific
socio-demographic characteristics (marital status that was
dichotomized in married/unmarried status and living status
that was dichotomized in living alone or not alone) together
with other variables such as family history of suicidal behavior,
comorbid panic disorder, previous psychiatric medications,
manifested melancholic features in the past, interepisodic
residual symptoms, current antidepressants use, and COPE
positive reinterpretation and growth was carried out to
investigate the contribution of these characteristics in predicting
presence/absence of SLE.
Multicollinearity and extreme cases were excluded, and the
normality of residuals (histograms and P–P plots) was
appropriately checked.
To assess whether the effect of current antidepressants use on
SLE was mediated by specific variables (i.e., previous psychiatric
medications, family history of suicide), single-mediator models
were tested according to the strategy recommended by Preacher
and Hayes (33). In a single-mediator model, an independent
variable (X = current antidepressants use) is hypothesized to act
on the outcome variable (Y = SLE) in two ways: X change a
mediator (e.g., Mi = previous psychiatric medications or family
history of suicide; path Ai) that, in turn, changes an outcome
variable (Y; path Bi), or X changes Y directly (path C′) (for more
details, see Figure 1).
The Statistical Package for Social Sciences (SPSS) for
Windows 21.0 was used to carry out all the statistical analyses.RESULTS
Socio-Demographic and Clinical Variables
of Outpatients With Significant Stressful
Life Events in the Previous 6 Months
Compared With Those Without
The sample includes 628 euthymic MDD outpatients who were
consecutively and voluntarily recruited at the outpatient service
of Department of Neuroscience (DINOGMI), University of
Genoa from the catchment area. Socio-demographic and
clinical features of outpatients are summarized in Table 1.September 2020 | Volume 11 | Article 566017
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and Associated Socio-Demographic and
Clinical Characteristics
Among subjects who were recruited, 250 (39.8%) reported
significant SLE in the previous 6 months and 378 (60.2%) did not.
Those reporting recent SLE [87 males (36.7%) and 163
females (41.7%)] differed from individuals who did not report
recent SLE. Specifically, when compared with those who did not
report recent SLE subjects with recent SLE differed in terms of
both marital and living status (c2(3)=12.963, p=.005; c2(3)=9.729,
p=≤.05), respectively.
Relative to outpatients without recent stressful life events, those
who have experienced these events were more likely to have a
family history of suicidal behavior (77.8 vs. 22.2%) (c2(1)=5.818,
p=≤.05), less likely to have a comorbid panic disorder (23.3 vs.
76.7%) (c2(1)=3.595, p=≤.05) and less likely to have used
psychiatric medications (42.2 vs. 57.8%) (c2(1)=6.000, p=≤.01).
When compared to subjects without SLE in the previous 6
months, subjects with recent stressful events were also more
likely to have exhibited melancholic characteristics in the past
(61.3 vs. 38.7%) (c2(1)=6.538, p=.01) and less likely to manifest
residual interepisodic symptoms (43.4 vs. 56.6%) (c2(1)=3.024,
p=≤.05) and use current antidepressant medications (36.7 vs.
63.3%) (c2(1)=9.273, p=≤.005).
The Kolmogorov–Smirnov test did not find any significant
abnormality concerning the continuous data. Moreover, subjects
with recent SLE were more likely to have a higher COPE positive
reinterpretation and growth (11.2 ± 5.9 vs. 10.3 ± 2.5, t457 = 9.422,
p ≤.05) when compared to those without SLE in the previous 6
months (for more details, see Tables 1 and 2).
Multivariate Regression Analyses
Including Stressful Life Events as
Dependent Variable in the Total Sample
All clinical variables which were significant at the univariate
analyses were entered into a binary logistic regression analysisFrontiers in Psychiatry | www.frontiersin.org 4with SLE as dependent variable in order to identify
independent factors which resulted associated with. Specific
socio-demographic characteristics such as marital and living
status as well as clinical variables (e.g., family history of suicidal
behavior, comorbid panic disorder, previous psychiatric
medications, manifested melancholic features in the past,
interepisodic residual symptoms, current antidepressants use,
and COPE positive reinterpretation and growth) were
introduced into the regression model. The amount of
variation in the first dependent variable (presence/absence of
recent SLE) that was accounted for all predictors (R2-value)
was 18.3% (p≤.001) (see Table 3).
Having a family history of suicide with an OR of 9.697
(p=≤.05), history of psychotropic medications use with an OR
of 2.888 (p=≤.01), and reduced use of antidepressant drugs with
an OR of .321 (p=.001) were all significantly associated with
recent SLE.
Mediation Analyses
In a regression model with current antidepressants use
and family history of suicide as predictors and SLE as
criterion, the regression models were both significant (R2 =
.020, B = -.590, SE=.195, Wald = 9.145, p = .002, OR = .554)
(R2 = .020, B = 1.738, SE=.809, Wald = 4.620, p = .032, OR =
5.687), respectively. When considering the effect of current
antidepressants use on SLE in a single mediator model
(considering first family history of suicide and later previous
psychiatric medications as possible mediators), the results were
as follows.
Family history of suicide had a significant direct effect on
SLE (family history of suicide: omnibus test of direct effect of
Mi on Y: R2 = .020, B = 1.738, SE=.809, Wald = 4.620, p = .032,
OR = 5.687) but a nonsignificant indirect effect (family history
of suicide: omnibus test of direct effect of X on Mi: R2 = .000,
B = -.012, SE=.811, Wald = .000, p = .988, OR = .988). Previous
psychiatric medications had a significant direct effect on SLEFIGURE 1 | Mediation model with potential mediators (Paths Ai: Variable i!Mediator; Paths Bi: Mediator!Dependent Variable; Path C’: Independent
Variable!Dependent Variable). *p = ≤ .05; **p = ≤ .01; ***p = ≤ .001.September 2020 | Volume 11 | Article 566017
Serafini et al. Stressful Life Events in MDDTABLE 1 | Socio-demographic and clinical variables (categorical and quantitative) in patients with significant distressing life-events in the last 6 months (N=250)
compared with those without (N=378).
Variables Subjects with significant
distressing life events in the
previous 6 months (N=250)
Subjects without significant
distressing life events in the
previous 6 months (N=378)
Statistic (c2) ♦p
N % N %
Gender
Male 87 36.7 150 63.3 c2(1)=1.527 .125*
Female 163 41.7 228 58.3
Marital status
Single 62 33.7 122 66.3 c2(3)=12.963 .005
Married 116 38.5 185 61.5
Divorced 35 43.8 45 56.3
Widowed 34 59.6 23 40.4
Living status
Alone 66 42.9 88 57.1 c2(3)=9.729 .021
With family 163 37.0 278 63.0
With friends 9 64.3 5 35.7
With others 6 75.0 2 25.0
Working status
Employed 113 40.6 165 59.4 c2(3)=3.635 .304
Unemployed 59 45.7 70 54.3
Retired 65 36.5 113 63.5
Student 8 30.8 18 69.2
Socio-economic level
Below average 76 39.6 116 60.4 c2(2)=.659 .719
Average 154 40.6 225 59.4
Above average 14 34.1 27 65.9
Positive history of psychiatric conditions in family
No 163 38.3 263 61.7 c2(1)=.367 .302*
Yes 78 40.8 113 59.2
Family history of suicidal behavior
No 144 38.1 234 61.9 c2(1)=5.818 .020*
Yes 7 77.8 2 22.2
Psychiatric comorbidity
No 197 40.3 292 59.7 c2(1)=.077 .431*
Yes 53 39.0 83 61.0
Comorbid anxiety
No 234 39.5 359 60.5 c2(1)=.747 .240*
Yes 16 47.1 18 52.9
Comorbid panic disorder
No 243 40.7 354 59.3 c2(1)=3.595 .041*
Yes 7 23.3 23 76.7
Comorbid phobias
No 247 39.6 376 60.4 c2(1)=2.072 .177*
Yes 3 75 1 25
Comorbid obsessive compulsive disorder
No 250 40.2 372 59.8 c2(1)=3.342 .078*
Yes 0 0.0 5 100
Comorbid post-traumatic stress disorder
No 250 39.9 376 60.1 c2(1)=.664 .601*
Yes 0 0.0 1 100.0
Comorbid personality disorder, cluster A
No 250 40 375 60.0 c2(1)=1.331 .361*
Yes 0 0.0 2 100.0
Comorbid personality disorder, cluster B
No 241 39.7 366 60.3 c2(1)=.227 .399*
Yes 9 45.0 11 55.0
Comorbid personality disorder, cluster C
No 247 39.7 375 60.3 c2(1)=.852 .315*
Yes 3 60.0 2 40.0
(Continued)Frontiers in Psychiatry | www.frontiersin.org 5 September 2020 | Volume 11 | Article 566017
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Variables Subjects with significant
distressing life events in the
previous 6 months (N=250)
Subjects without significant
distressing life events in the
previous 6 months (N=378)
Statistic (c2) ♦p
N % N %
Psychiatric medications in the past
No 36 30.0 84 70.0 c2(1)=6.000 .009*
Yes 213 42.2 292 57.8
Non psychiatric medications in the past
No 121 41.0 174 59.0 c2(1)=.379 .297*
Yes 127 38.6 202 61.4
Lifetime substance abuse/dependence
No 237 39.8 359 60.2 c2(1)=.003 .563*
Yes 11 39.3 17 60.7
Psychotherapy in the past
No 203 39.3 313 60.7 c2(1)=.002 .523*
Yes 40 39.6 61 60.4
Single/recurrent episode
Single 129 41.5 182 58.5 c2(1)=.842 .203*
Recurrent 93 37.7 154 62.3
First depressive episode
Depressive 9 23.1 30 72.9 c2(1)=.237 .414*
Nondepressive 9 28.1 23 71.9
Current catatonic characteristics
No 159 39.7 242 60.3 c2(1)=1.962 .222*
Yes 0 0.0 3 100.0
Current melancholic characteristics
No 141 37.9 231 62.1 c2(1)=6.538 .010*
Yes 19 61.3 12 38.7
Current atypical depressive characteristics
No 153 40.3 227 59.7 c2(1)=.875 .239*
Yes 7 30.4 16 69.6
Psychotic symptoms at first episode
No 140 40.2 208 59.8 c2(1)=1.573 .176*
Yes 6 60.0 4 40
BMI
<18 10 50.0 10 50.0 c2(3)=4.977 .173
18–25 191 41.7 267 58.3
25–30 39 32.0 83 68.0
>30 9 34.6 17 65.4
Residual interepisodic symptoms
No 116 36.4 203 63.6 c2(1)=3.024 .049*
Yes 118 43.4 154 56.6
Lifetime suicide attempts
None 240 40.3 183 92.9 c2(2)=2.292 .318
0–3 7 25.9 13 6.6
>3 1 33.3 0 0.0
Seasonality
No 144 39.0 225 61.0 c2(1)=.649 .340
Yes 2 25.0 6 75.0
Adherence to treatment
Bad 11 36.7 19 63.3 c2(1)=.43 .500*
Good 132 38.6 210 61.4
Current anxyolitic medications
None 96 41.6 135 58.4 c2(3)=.641 .887
Short half-life 75 38.9 118 61.1
Middle half-life 57 37.7 94 62.3
High half-life 19 40.4 28 59.6
Current antidepressant medications
No 70 51.1 67 48.9 c2(1)=9.273 .002*
Yes 179 36.7 309 63.3
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of Mi on Y: R2 = .013, B = .532, SE=.219, Wald = 5.917, p = .015,
OR = 1.702) and a significant indirect effect (previous
psychiatric medications: omnibus test of direct effect of X on
Mi: R2 = .121, B = 1.561, SE=.219, Wald = 50.777, p = <.001,
OR = 4.765).Frontiers in Psychiatry | www.frontiersin.org 7DISCUSSION
Our study investigating the association of recent SLE in euthymic
depressive patients indicated that the experience of recent stressful
events was associated with several clinical, course, and
sociodemographic characteristics, some of which may be clinicallyTABLE 1 | Continued
Variables Subjects with significant
distressing life events in the
previous 6 months (N=250)
Subjects without significant
distressing life events in the
previous 6 months (N=378)
Statistic (c2) ♦p
N % N %
Personal autonomy
Bad 18 52.9 140 38.3 c2(1)=2.809 .069*
Good 16 47.1 226 61.7
Subjects with significant
distressing life-events in the
previous 6 months (N=250)
Subjects without significant
distressing life-events in the
previous 6 months (N=378)
Statistic (Student’s t-test) p
Mean SD Mean SD
Current age 55.1 15.7 54.8 16.4 T626=-.605 .841
Educational level (years) 11.3 3.5 11.6 3.5 T583=.426 .332
Number of illness episodes 1.8 1.4 1.9 1.5 T499 = 1.202 .549
Age at first treatment 47.8 16.7 45.2 16.6 T550=.055 .084
Duration of untreated illness (years) 3.7 26.4 1.7 3.3 T468 = 4.582 .223
Duration of illness (years) 9.6 12.9 11.8 14.2 T528 = 2.455 .070
Duration of substance abuse (years) 0.4 2.5 0.4 2.4 T609=-.017 .962
MADRS total score 6.5 3.3 6.2 3.5 T203 = 1.686 .530
CGI severity (item 1) 2.1 4.1 1.4 2.5 T174 = 5.844 .139
BHS total score 10.7 6.2 11.03 5.8 T429=.619 .545
HARS total score 7.9 8.4 8.2 7.5 T174=.864 .791
GAF Mental Composite Score 11.1 2.5 11.6 4.2 T463=.560 .161
GAF Physical Composite Score 14.9 1.9 14.8 1.8 T450 = 1.732 .790
CTQ emotional abuse 3.2 5.03 3.3 4.7 T422=.149 .842
CTQ physical abuse 1.5 3.2 1.6 4.01 T440=.303 .800
CTQ sexual abuse 1.7 4.1 1.2 3.5 T431 = 7.205 .177
CTQ emotional neglect 13.1 7.1 14.04 6.7 T425=.775 .188
CTQ physical neglect 5.3 3.4 5.2 3.5 T119=.311 .917
COPE active 11.2 5.9 10.3 2.5 T457=.9422 .036
COPE planning 10.6 4.6 10.5 3.6 T445=.908 .877
COPE suppression 10.1 5.1 9.9 3.4 T453 = 2.102 .643
COPE behavioral disengagement 8.8 3.6 9.1 4.2 T449=.101 .477
COPE denial 7.7 4.4 7.3 2.4 T450 = 3.111 .147
COPE mental disengagement 8.9 2.6 9.1 4.2 T446=.082 .553
COPE substance abuse 5.02 2.3 5.3 3.1 T460 = 2.211 .286
COPE emotional social support 4.4 72.6 9.7 3.9 T454 = 2.983 .234
COPE instrumental social support 10.5 4.6 10.3 3.6 T466=.699 .727
COPE venting emotions 10.7 4.7 10.2 3.3 T443 = 1.384 .138
COPE positive reinterpretations 10.1 4.3 10.2 3.8 T468=.603 .904
COPE restraint 9.7 5.1 10.3 4.8 T445=.066 .188
COPE acceptance 9.9 3.6 10.1 4.8 T447=.048 .652
COPE turning to religion 8.8 5.3 8.6 4.5 T460=.142 .670
COPE humor 6.7 2.9 6.7 3.02 T433=.045 .879
TAS total score 63.2 13.6 63.8 18.6 T370 = 1.237 .710
TAS difficulties in identifying feelings 17.4 7.1 17.5 8.9 T419=.090 .874
TAS difficulties in communicating feelings to others 15.3 4.4 15.4 5.7 T425=.020 .833
TAS thoughts oriented to external context 27.7 5.4 28.6 9.2 T431 = 3.091 .246
DAI total score 12.9 4.3 14.03 4.8 T277=.897 .066September 2020 | Volume 11 | Article 56BHS, Beck Hopelessness Scale; COPE, Coping Orientation to the Problems Experienced; CTQ, Childhood Trauma Questionnaire; DAI, Drug Attitude Inventory; HARS, Hamilton
Anxiety Rating Scale; MADRS, Montgomery-Asberg Depression Rating Scale; TAS, Toronto Alexithymia Scale; *Fisher’s exact test (significance two-tailed); percentages were
calculated per column.6017
Serafini et al. Stressful Life Events in MDDTABLE 2 | Medical comorbidity in patients with significant distressing life-events in the previous 6 months (N=250) compared with those without (N=378).
Subjects with significant distressing
life-events in the previous 6 months
(N=250)
Subjects without significant distressing
life-events in the previous 6 months
(N=378)
Statistic (c2) p
N % N %
Medical comorbidities
No 143 65.0 77 35.0 c2(1)=3.193 .064*
Yes 233 57.7 171 42.3
Neurological comorbid disorders
No 358 60.6 233 39.4 c2(1)= .475 .304*
Yes 18 54.5 15 45.5
Cardiological comorbid disorders
No 175 89.3 170 95.0 c2(1)=.001 .555*
Yes 21 10.7 9 5.0
Endocrinological comorbid disorders
No 341 59.5 232 40.5 c2(1)=1.625 .130*
Yes 35 68.6 16 31.4
Inflammatory/immunological comorbid disorders
No 342 59.8 230 40.2 c2(1)=.623 .262*
Yes 34 65.4 18 34.6
Metabolic disorders
No 366 60.4 240 39.6 c2(1)=.171 .427*
Yes 10 55.6 8 44.4
Mild cognitive impairment (amnesic)
No 196 100.0 178 99.4 c2(1)=1.098 .477*
Yes 0 0.0 1 0.6
Comorbid polmonary diseases
No 194 99.0 179 100.0 c2(1)=1.836 .273*
Yes 2 1.0 0 0.0
Comorbid cancer
No 189 96.4 169 94.4 c2(1)= .878 .246*
Yes 7 3.6 10 5.6
Comorbid chronic renal failure
No 196 100.0 178 99.4 c2(1)= 1.098 .477*
Yes 0 0.0 1 0.6
Comorbid HIV
No 194 99.0 179 100.0 c2(1)=1.836 .273*
Yes 1 1.0 1 0.0Frontiers in Psychiatry | www.frontiersin.org 8 September 2020 | Volume 11 | Article 56*HIV, human immunodeficiency virus; Fisher’s exact test (significance two-tailed); percentages were calculated per column.TABLE 3 | Multiple regression model of significant distressing life-events in the previous 6 months in the total sample (N=628).
Variable B SE Wald P OR 95% Cl OR
Lower Upper
Married status .021 .276 .006 .940 1.021 .595 1.754
Living status −.010 .010 1.136 .286 .990 .971 1.009
Family history of suicide 2.272 1.146 3.931 .047 9.697 1.026 91.629
Comorbid panic disorders −1.022 .681 2.248 .134 .360 .095 1.369
Previous psychiatric medications 1.061 .406 6.808 .009 2.888 1.302 6.407
Melancholic features in the past .864 .592 2.129 .145 2.373 .743 7.576
Interepisodic residual symptoms .391 .290 1.819 .177 1.479 .838 2.610
Current antidepressants use −1.136 .349 10.627 .001 .321 .162 .636
COPE active .065 .037 3.054 .081 1.067 9.92 1.147
Constant −2.814 .910 9.572 .002 .060Dependent variable: SLE. All predictors were entered in one block (hierarchical method). Model summary: R=.113, R2=.153; significance: P=≤.001. Bold values denote statistical
significance.6017
Serafini et al. Stressful Life Events in MDDutilizable in understanding and managing the culminating effect of
life stressors in influencing illness course and outcome.
Socio-Demographic Characteristics of
Outpatients With Significant Stressful Life
Events in the Previous 6 Months
Compared With Those Without
Euthymic outpatients who experienced SLE differed from those
who did not experience SLE in terms of both marital and
living status.
Existing evidence suggested that being widowed is generally
perceived as one of the most SLE (34) linked to relevant
impairments in the general well-being of the bereaved spouse.
According to previously published studies (35), widowers and
widows should be considered at higher risk to experience lower
subjective well-being even several years after the death of the
spouse. In line with these findings, Carnelley and colleagues (36)
found that widowers/widows experienced a significant distress
and reduced subjective wellbeing even decades after the death.
Similarly, we found a higher ratio of those widowed among those
experiencing recent distressing events.
On the other hand, conversely to existing evidence suggesting
that subjects who have more contact with friends and family are
happier than those who have less contact (37), we found that
outpatients who experienced SLE lived predominantly with
friends or others. However, living with family rather than
living with friends may be generally interpreted as a protective
factor for MDD patients. This discrepancy could be related, in
our opinion, to the fact that, although being recruited in stable
psychopathological conditions, participants of the present study
are predominantly affected by MDD (single episode) which is a
condition for which many of them might have searched a
significant social contact or asked support due to their illness.
Clinical Characteristics of Euthymic
Outpatients Experiencing Significant
Stressful Life Events in the Previous 6
Months Compared With Those Without
As for clinical variables, outpatients experiencing significant SLE were
more likely to have a family history of suicidal behavior, manifested
melancholic features in the past, report a higher COPE positive
reinterpretation and growth, and less likely to have a comorbid panic
disorder, residual interepisodic symptoms, past psychiatric
medication use, and current antidepressant medication use.
In line with previous evidence (38) suggesting that the
occurrence of SLE was higher and the associated perceived
experience was more deleterious in suicidal patients, we found
an association between SLE in the previous six months and
family history of suicidal behavior. Specifically, this could be
explained by the assumption that the interpersonal pattern
linked to family history of suicide may consistently influence
the ability to maintain stable and significant relations with others
as supported by Rajalin and colleagues (39).
Moreover, we found that subjects with recent SLE were more
likely to have manifested melancholic features in the past. Existing
studies analyzed the association between depression subtypes andFrontiers in Psychiatry | www.frontiersin.org 9the likelihood to experience life adverisities. For instance, Kohn and
colleagues (40) reported that, in a sample of 115 MDD patients,
subjects with nonmelancholic depression or first depressive episode
more frequently experienced ≥3 life adversities when compared to
severe, melancholic, or recurrent depression. However, they
investigated only a subset of MDD patients which is more prone
to suffer from a cluster of negative life events. In addition, while the
study of Kohn and colleagues (40) analyzed a sample of patients
with mild-moderate depression, we investigated a larger (N=628)
sample of MDD euthymic subjects. Thus, the main differences
between our study and the study of Kohn and colleagues (40) may
be related to the different study sample selection and different
clinical characteristics.
Finally, we found that those who experienced SLE were more
likely to report higher COPE positive reinterpretation and
growth. This may be explained by the fact that the attitudes to
cope with stress in our MDD patients, the psychopathological
conditions of which were stable for at least 6 months before
assessment, were more pronounced than those of other patient
populations. Clinicians and health professionals should take
appropriately into account these data in order to conduct
psychotherapeutic interventions which are directed toward
further coping with stress and create treatment strategies
which may result especially useful in improving functional
capacity in the identified stable phases of MDD.
Predictors of Stressful Life Events and
Mediators of the Associations With
Stressful Life Events
After binary regression analysis, MDD patients with recent SLE
were more likely to have a family history of suicide (OR=9.68)
and a history of psychotropic medications use (OR=2.89), but
they were less likely to use currently antidepressants (OR=.32).
In particular, outpatients who have experienced recent SLE were
more likely to report a family history of suicide, more likely to
have used previous psychiatric medications, and less likely to
currently use antidepressants drugs that those without recent
SLE in the previous 6 months.
Generally, having a family history of suicidal behavior is also
associated with a greater propensity to SLE; thus, clinicians should
be warned about carefully searching for suicidal thoughts in this
patient subgroup as these individuals might exhibit a worse
combination of biological, psychological, and environmental risk
for suicide. In particular, in individuals with family history of
suicidal behavior, the increased likelihood to experience stressful
life events may enhance the perception of fewer reasons for living,
thus elevating the risk of suicidal behavior, although in our study we
did not observe significant differences in terms of suicide attempts
between those with and without recent stressful life events.
Consistent with this hypothesis, evidence documented that having
a family history of suicide or attempted suicide is a significant risk
factor for suicidal behavior and supposed the existence of a specific
genetic component of suicidal behavior (41, 42). In line with these
results, Rajalin and colleagues (39), recently found in a sample of
181 suicide attempters that having a family history of suicide was
linked to factor 2 (nonassertive; exploitable; overly nurturant, andSeptember 2020 | Volume 11 | Article 566017
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of Interpersonal Problems (IIP). Subjects with higher scores in the
Intrusive subscale of the IIP are described to be excessively
controlling, not careful to respect individual and other´s
boundaries as well as more prone to take charge of other subjects’
problems (39). This may imply that these individuals pervasively
experience disappointment and presumably reject in social contexts
appearing unable to identify themselves in positive arguments with
others. According to these findings, subjects who have experienced
recent SLE and report a positive history of suicide among family
members seem to exhibit specific deficits in interpersonal
functioning. Moreover, evidence (43) clearly suggested that having
a family history of suicidemay be considered not only as a biological
but also a psychological risk factor for familial transmission of
suicide. Unfortunately, in our study we were not able to investigate
the impact of interpersonal difficulties in subjects with family
history of suicidal behavior who have also experienced recent
SLE. In addition to the identified at risk profile, the participants
of our study were also more likely to be widowed and have used
psychiatric medications in the past.
Surprisingly, after multivariate analysis, subjects with
significant SLE were less likely to currently use antidepressant
drugs compared to those without recent stressful life events. This
finding may be presumably explained by the fact that the
majority of our study participants suffer predominantly from
reactive and situational depression, but it is also possible that
individuals who experienced recent SLE in our study may rely on
more resilient social groups in which they received social support
even in the context of negative interpersonal events or may have
benefited from a psychotherapeutic approach. Such support may
have helped them to better cope with SLE, thus reducing the
current use of antidepressant medications. However, most
patients do not frequently consult psychiatrists or mental
health professionals due to stigma and discrimination as well
as fear of disability and chronicity related to psychiatric
conditions. This may, at least partially, justify the reduced or
absent psychiatric services attendance in the past.
Finally, according to mediation analyses the association between
the reduced use of antidepressant drugs and SLE was mediated by
the history of psychotropic medications use. Thus, with this result
we confirm the initial hypothesis based on which previous
psychiatric medications had a significant direct/indirect effect on
SLE. Specifically, subjects with a reduced use of antidepressants may
be more vulnerable to experience SLE, in particular whether they
have been treated in the past with psychiatric medications (that may
have been prematurely discontinued by patients). This result is in
line with the questioned long-term partial benefits of psychiatric
medications (44) and may reflect, in our opinion, the limited
potential of these compounds, which are detrimentally
interrupted by patients on their own initiative (45, 46), on
protecting against long-term exposure to stressors.
Unfortunately, whether the use of pharmacological medications
is not combined with other available treatment strategies (e.g.,
psychotherapy), depressed individuals who have been treated
only with psychoactive agents may be insufficiently protected in
the long-term period towards potential illness recurrences (47,Frontiers in Psychiatry | www.frontiersin.org 1048) neither they seem to have developed specific coping strategies
to successfully cope with psychosocial distress in daily life. To
further confirm our findings, it has been reported that the
current use of antidepressants may help subjects to face intense
emotional stimuli and stressful cues (49), presumably by
attenuating the brain expression and/or actions of pro-
inflammatory mediators. Here, we add that having undergone
a psychiatric treatment (that may have been prematurely
discontinued) is associated with the more frequent occurrence
of SLE, if MDD patients are not adequately treated with
antidepressant medications.LIMITATIONS OF THE STUDY
The present study should be considered in the light of the following
limitations/shortcomings. First, SLE were not measured using
specific psychometric instruments such as the Social
Readjustment Rating Scale (SRRS) which assesses the frequency
of 43 common stressful life events occurring over the previous 12
months (34), that would allow us to rate the impact of specific
stressful life experiences on a specific severity scale. In addition, we
were also unable to use specific psychometric tools like the
Karolinska Self Harm History Interview (50), including specific
questions regarding family history of suicidal behavior in order to
investigate the family history of completed suicide in a more
detailed manner. In addition, the cross-sectional nature of the
present study potentially leading to type I errors needs to be
considered as an additional caveat. Moreover, we were not able to
collect information regarding positive life events in the present
study and thus we mainly explored the impact of negative ones.
Additionally, by setting a P value of ≤.05, some significant
differences in our univariate analyses may lead to false-positive
findings due to multiple comparisons. Unfortunately, we were not
able to apply an adjustment for multiple comparisons (e.g.,
Bonferroni’s adjustment)
Furthermore, we mainly analyzed a specific list of SLE:
maltreatment and violence; loss events; intrafamilial problems;
school and interpersonal problems based on our clinical
experience as well as according to previously published studies
(3, 4) without considering other types of SLE such as specific
interpersonal stressors that may influence the onset/maintenance
of depression in specific sociocultural environments (39).
Additionally, we did not take into account the possible link
between the time from the occurrence of these events and recent
SLE. For instance, one can inquire that having experienced the
loss of a loved one by suicide even in the past may have
influenced the likelihood to experience recent SLE. Although
we did not find in our sample any recent loss event directly
related to the loss of a loved one by suicide, the association
between family history of suicide in the past and SLE may be
affected by this caveat. Furthermore, we were not able in this
study to investigate the effect of previous SLE, such as childhood
traumatic experiences. Moreover, psychological factors which
may further enhance the risk of negative outcome such as
neuroticism, that were comprehensively examined in existingSeptember 2020 | Volume 11 | Article 566017
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potential protective factors like social support (51) or coping
skills (52) were not taken specifically into account. Finally, while
previous studies (53) supported a significant dose-response effect
of the number of life events on illness course and outcome, here
we were not able to identify the exact number of SLE.
However, despite the mentioned shortcomings, the recruitment
of a large homogeneous sample of outpatients with MDDwho were
clearly euthymic together with the investigation of the effects of a
comprehensive set of potential socio-demographic and clinical
variables on the outcome need to be considered as major
strengths of this study.CONCLUSION
Having a family history of suicide and history of psychotropic
medications use but even the reduced use of antidepressant
drugs, of which some (e.g., duloxetine) act as inhibitors of both
norepinephrine and serotonin transporters (54) and others (e.g.,
agomelatine) are of particular interest due to their ability to
enhance neuroplasticity mechanisms (55), may reflect a specific
“at risk” clinical profile characterized by the enhanced
vulnerability to experience SLE. This finding is in line with the
expression of a complement of genes that correlates with the
degree of adversity, based on the assumption that early
adversities may predispose selective molecular systems and
related gene expression profiles associated with impaired
stress response and/or differences in the sensitivity of specific
genes involved in the response to stress signals (56, 57).
Further additional studies are needed in order to test these
exploratory findings.Frontiers in Psychiatry | www.frontiersin.org 11DATA AVAILABILITY STATEMENT
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